Talis Biomedical Corp
TLISDelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001584751
Talis Biomedical Corp was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Sep 9, 2024; 18 institutions reported holding it in 13F filings for Q2 2024, worth $6.84M in total; Greenlight Capital was the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Talis Biomedical Corp changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 45 | 3 | 35 | −7 |
| Shares | 16.7M | 162.9K | 14.9M | −1.67M (−10.1%) |
| Value | $23.6M | $230.0K | $12.1M | −$11.3M (−48.2%) |
3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Talis Biomedical Corp at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Newtyn Management, LLC | 284,726 | $231.0K | 0.04% |
| Millennium Management LLC | 201,913 | $164.0K | 0.00% |
| Ergoteles LLC | 69,424 | $56.0K | 0.00% |
| Citadel Advisors LLC | 42,242 | $34.0K | 0.00% |
| Goldman Sachs Group Inc | 23,242 | $19.0K | 0.00% |
| Virtu Financial LLC | 20,061 | $16.0K | 0.00% |
| M&T Bank Corp | 11,756 | $10.0K | 0.00% |
| Credit Suisse AG | 8 | $0 | 0.00% |
| First Horizon Advisors, Inc. | 582 | $0 | 0.00% |
Sold out (16)
Institutions that held Talis Biomedical Corp at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Nuveen Asset Management, LLC | 53,809 | $82.0K |
| Bridgeway Capital Management, LLC | 54,000 | $76.0K |
| Bank of New York Mellon Corp | 52,462 | $74.0K |
| Charles Schwab Investment Management Inc | 31,324 | $45.0K |
| Two Sigma Advisers, LP | 23,800 | $34.0K |
| Tower Research Capital LLC (TRC) | 15,767 | $22.0K |
| Rhumbline Advisers | 11,403 | $16.0K |
| American International Group, Inc. | 7,355 | $10.0K |
| JPMorgan Chase & Co | 6,948 | $10.0K |
| California State Teachers Retirement System | 6,552 | $9.00K |
| Barclays PLC | 3,441 | $5.00K |
| Amalgamated Bank | 1,803 | $3.00K |
| Legal & General Group Plc | 1,074 | $2.00K |
| Ameritas Investment Partners, Inc. | 1,077 | $2.00K |
| Toronto Dominion Bank | 2 | $0 |
| Capital Advisors, Ltd. LLC | 117 | $0 |
Not filed for Q2 2022 yet (3)
Institutions that held Talis Biomedical Corp at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 138,917 | $196.0K |
| Golden State Equity Partners | 22,133 | $31.0K |
| Amalgamated Financial Corp. | 1,803 | $3.00K |